INCR Profile
InterCure Ltd., headquartered in Herzliya, Israel, operates as a prominent player in the global medical cannabis industry, encompassing a comprehensive portfolio of activities spanning research, cultivation, production, marketing, and distribution. Established in 1994, the company has established itself as a leader in leveraging cannabis for therapeutic applications, catering to both domestic and international markets.
At the heart of InterCure Ltd.'s operations are its diversified product offerings, which include dried cannabis inflorescences and cannabis extracts blended with oils. These products are meticulously crafted to meet stringent quality standards and cater to a wide spectrum of medical needs, offering patients effective treatment options backed by scientific research and clinical trials.
In addition to its core cannabis operations, InterCure Ltd. maintains a strategic focus on investments within the biomed sector. By actively pursuing opportunities in biotechnology and healthcare innovations, the company aims to expand its footprint and diversify its revenue streams, driving sustainable growth and value creation for its stakeholders.
Led by a visionary management team with expertise in healthcare and pharmaceutical sectors, InterCure Ltd. continues to pioneer advancements in medical cannabis research and development. The company's commitment to innovation, regulatory compliance, and patient-centric care underscores its role as a trusted partner in the evolving landscape of medical cannabis, poised to capitalize on emerging market opportunities and enhance healthcare outcomes globally.
|
